EUCTR2008-006439-12-IT进行中（未招募）1 期
Strategic Timing of Antiretroviral Treatment - START
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 4,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •HIV infection, age>18 year karnosfky index > 80, Perceived life expectancy of at least 6 months; CD4> 500 cell
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any previous use of ART or IL-2, Diagnosis of any clinical AIDS event; Cardiovascular event; History of decompensated liver disease; Current pregnancy or breastfeeding
研究者
相似试验
已完成
4 期
Strategic Timing of AntiRetroviral TreatmentHIV-InfectionDRKS00000374niversity of Minnesota Clinical and Translational Science Institute4,625
进行中（未招募）
不适用
Strategic Timing of AntiRetroviral Treatment (START)EUCTR2008-006439-12-GBRegents of the University of Minnesota4,000
进行中（未招募）
1 期
Strategic Timing of AntiRetroviral Treatment (START) - STARTEUCTR2008-006439-12-IERegents of the University of Minnesota4,600
进行中（未招募）
不适用
Strategic Timing of AntiRetroviral Treatment (START) - STARTHIV InfectionEUCTR2008-006439-12-GRRegents of the University of Minnesota4,000
进行中（未招募）
1 期
START studyEUCTR2008-006439-12-CZRegents of the University of Minnesota4,600